07.02.2013 Views

jurnalul român de psihofarmacologie romanian journal of ...

jurnalul român de psihofarmacologie romanian journal of ...

jurnalul român de psihofarmacologie romanian journal of ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

- siguranţa şi eficacitatea;<br />

- tolerabilitatea;<br />

- disfuncţia cognitivă;<br />

- efectele asupra unor subgrupuri ale populaţiei (<strong>de</strong> ex., grupuri culturale şi genetice,<br />

grupuri speciale <strong>de</strong> pacienţi etc);<br />

- date farmaco-economice care să compare antipsihoticele din generaţia a doua cu<br />

antipsihoticele convenţionale;<br />

- percepţia subiectivă a beneficiilor tratamentului.<br />

3. GHIDURI ŞI ALGORITMI DE TRATAMENT<br />

Pentru a veni în sprijinul psihiatrilor şi pentru a furniza logica ştiinţifică a <strong>de</strong>ciziilor lor<br />

terapeutice pe baza celor mai recente informaţii ştiinţifice, societăţile pr<strong>of</strong>esionale naţionale trebuie<br />

să furnizeze continuu tuturor celor implicaţi ghiduri şi algoritmi actualizaţi.<br />

Aceasta ilustrează, însă, cererea pentru cercetare şi educaţie continuă a tuturor oamenilor <strong>de</strong><br />

ştiinţă implicaţi.<br />

Bibliografie<br />

1. Knapp MRJ, Kavanagh S. Economic outcomes and costs in the treatment <strong>of</strong> schizophrenia.<br />

Clin Ther 1997; 19:128-138; discussion 126-127.<br />

2. Knapp MRJ. Making music out <strong>of</strong> noise – the cost function approach to evaluation. Br J<br />

Psychiatry 1998; 36(Suppl.):7-11.<br />

3. Knapp MRJ. Schizophrenia costs and treatment cost-effectiveness. Acta psychiatr Scand<br />

2000; 102(Suppl.):15-18.<br />

4. Haro JM, Salvador-Carulla L, Cabases J, Madoz V, Vasquez-Barquero JL. Utilization <strong>of</strong><br />

mental health services and costs <strong>of</strong> patients with schizophrenia in three areas <strong>of</strong> Spain. Br J<br />

Psychiatry 1998; 173:334-340.<br />

5. Kissling W, H<strong>of</strong>fler J, Seemann U, Muller P, Ruther E, Trenckmann U, Uber A, Graf von<br />

<strong>de</strong>r Schulenburg JM, Glaser P, Glaser T, Mast O, Schmidt D. [Direct and indirect cost <strong>of</strong><br />

schizophrenia]. Fortschr Neurol Psychiatr 1999; 67:29-36.<br />

6. Lindstrom LH, Wieselgren IM. Schizophrenia and antipsychotic somatic treatment. Int J<br />

Technol Asses Health Care 1996; 12:573-584.<br />

7. Rice DP, Miller LS. Health economics and cost implications <strong>of</strong> anxiety and other mental<br />

disor<strong>de</strong>rs in the United States. Br J Psychiatry 1998; 34(Suppl.):4-9.<br />

8. Suleiman TG, Ohaeri JU, Lawal RA, Haruna AY, Orija OB. Financial cost <strong>of</strong> treating outpatients<br />

with schizophrenia in Nigeria. Br J Psychiatry 1997; 171:364-368.<br />

167

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!